Evaluation of Three Types of Dressings After Hip Surgery

Phase 4

Completed

• Conditions: Tape Blisters; Hip Surgery
• Interventions: Device: Dressing of wound

• Registration Number: NCT01469871
• Lead Sponsor: Hopital de l'Enfant-Jesus

Brief Summary

The purpose of this study is to determine if one of the new types of dressings (MEPORE PRO and/or MEPILEX BORDER ) will reduce the blister rate compared to the currently used HYPAFIX.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-02
• Primary Completion: 2010-01
• Study Completion: 2010-01
• Status Verified: 2011-11
• Study First Submitted: 2011-11-04
• Study First Submitted QC: 2011-11-09
• Last Update Submitted: 2011-11-09
• Study First Posted: 2011-11-10
• Last Update Posted: 2011-11-10

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

• Male or Female 45 years old or older
• Hip surgery at Hopital de l'Enfant-Jesus between 02/2009 and 01/2010 (THR,rTHR, DHS, screw fixation, hemiarthroplasty, resurfacing)
• Signed consent form

Exclusion Criteria

• Allergy to dressing
• Polytrauma / high energy trauma
• Wound at the surgical site prior to surgery
• Neurological deficit of operated side (hemiplegia, etc.)
• Bilateral fracture

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Hypafix Transparent dressing	Dressing of wound	The Hypafix Transparent dressing, a stretchable dressing, will be used to treat the patients in this group
Mepore Pro dressing	Dressing of wound	The Mepore Pro dressing, a self-adhesive perforated dressing, will be used to treat the patients in this group
Mepilex Border dressing	Dressing of wound	The Mepilex Border dressing, a self-adherent soft silicone dressing, will be used to treat the patients in this group

Primary Outcome Measures

Name	Time	Method
The prevalence of tape blisters after hip fracture surgery	Participants will be followed for the duration of hospital stay, an expected average of 8 days

Secondary Outcome Measures

Name	Time	Method
Length of hospital stay	Participants will be followed for the duration of hospital stay, an expected average of 8 days
The correlation between risk factors and tape blisters	Participants will be followed for the duration of hospital stay, an expected average of 8 days
The possible link between the presence of tape blisters and hospital morbidity.	Participants will be followed for the duration of hospital stay, an expected average of 8 days
The costs related to a tape blister.	Participants will be followed for the duration of hospital stay, an expected average of 8 days	The actual costs related to a tape blister will be calculated by adding the costs of additional dressings, the costs associated with an extended hospital stay and the additional costs associated with the use of external resources.

Trial Locations

Locations (1)

Centre hospitalier affilié universitaire de Quebec - Hopital l'Enfant-Jesus; 🇨🇦 Quebec, Canada